InsidersTradesSigma
Follow the 녹십자웰빙 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 녹십자웰빙 has recorded 5 insider filings. Market capitalisation: €142.5bn. The latest transaction was filed on 9 April 2026 (Sale). Among the most active insiders: 녹십자홀딩스. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€115m
3 ops.
Buy Volume
€644,630
2 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,018 of 29,063 companies
51.1
score / 100
Value57
Quality46
FCF yld-0.3%
Earn yld6.6%
EV/EBITDA10.3x
ROE1.7%
Gross mgn45%
Net mgn6.1%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 April 2026
Declarations5 total
1 sharesKRXDART:20260409002300
5 of 5 declarations
关于 녹십자웰빙
녹십자웰빙 是一家在健康和制药领域运营的韩国公司。该公司在 XKRX 证券交易所上市。